Bifidobacterium lactis and Oral Health
Bifidobacterium lactis has been investigated in oral-health research, but systematic reviewers describe the evidence as uncertain and in need of higher-quality trials.
Key takeaways
- Bifidobacterium evidence is not uniformly positive.
- The exact strain matters.
- ProDentim’s seller lists B. lactis BL-04, which should not be conflated with studies of other B. lactis strains.
What systematic reviews say
A systematic review of randomized trials of Bifidobacterium probiotics found mixed results and judged the available evidence moderate in quality, with substantial risk-of-bias concerns. The authors called for better trials and clearer dosing information.
Why strain identity matters here
B. lactis is a species-level label. Research on HN019, BB-12 or another strain does not necessarily establish an effect for BL-04. Consumer articles frequently blur this distinction.
ProDentim context
The seller currently names B. lactis BL-04. That is useful label information, but DentalBiome does not treat studies of different B. lactis strains as direct proof for BL-04 or for the finished ProDentim formula.
Sources & evidence
- Systematic review of Bifidobacterium probiotics and oral health
- ProDentim official product presentation